Vaccine adjuvant protects against post-burn infection
Friday, April 1, 2016 - 12:20
in Health & Medicine
Research findings suggest that the use of a FDA-approved drug may serve a dual purpose by protecting people who are at high risk of infection, including those with severe burns, cancer, and other conditions that may compromise their immune systems' ability to ward off disease.